Goodwin assisted OQC on the financing round. Quantum Exponential Group plc (AQUIS: QBIT), the UK’s only pure quantum investment fund and accelerator, announced that its portfolio company, Oxford Quantum Circuits...
You must be a Standard 1 Year member to access this content.
Goodwin advised CMR Surgical on the recent fundraising. CMR Surgical has raised $165 million in a round led by all of its major existing investors, including Ally Bridge...
You must be a Standard 1 Year member to access this content.
Davis Polk & Wardwell, Mayer Brown, and Mishcon de Reya advised Gilead, while Goodwin Procter and Wilson Sonsini Goodrich & Rosati advised MiroBio on the deal....
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati and Goodwin advised MiroBio on the deal. MiroBio, a leader in the development of checkpoint agonists to treat autoimmune diseases, announced...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised 83North and Octopus Ventures on the deal. 83North and Octopus Ventures announced their lead investment into Ibex Medical Analytics, an Israeli based AI-powered...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised Vaccitech on the deal. Vaccitech announced the completion of its $168 million Series B, including the conversion of $43 million in convertible loan...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised Evox Therapeutics on the deal. Evox Therapeutics, leading exosome therapeutics company, announced its £69.2 million Series C financing round. The financing was significantly...
You must be a Standard 1 Year member to access this content.
